Table 2. A comparison of the distribution of patients’ clinical features and diagnostic definitions according to the severity of obesity .
|
- |
Mild (n=124) |
Moderate (n=192) |
Severe (n=105) |
p |
|
PCOS |
9 (7.2%) |
19 (9.9%) |
7 (6.6%) |
0.553 |
|
At risk for PCOS |
59 (47.5%) |
93 (48.4%) |
48 (45.7%) |
0.904 |
|
Menstrual irregularity |
39 (31.4%) |
60 (31.2%) |
27 (25.7%) |
0.553 |
|
Clinical hyperandrogenism |
47 (37.9%) |
60 (31.2%) |
27 (25.7%) |
0.384 |
|
Biochemical hyperandrogenemia |
27 (21.7%)a |
59 (30.7%)b |
34 (32.3%)b |
0.014* |
|
Polycystic ovary morphology |
16 (12.9%) |
28 (14.5%) |
13 (12.3%) |
0.926 |
|
Insulin resistance |
10 (8.0%)a |
37 (19.2%)b |
34 (32.3%)c |
<0.001* |
*p<0.05. Chi-square test was used for categorical data comparison. Bonferroni test was applied in post-hoc analyses. Statistically significant differences and similarities are shown by superscripts (a, b, c).
PCOS: polycystic ovary syndrome